Question 1

What are patient platforms in investing?

Accepted Answer

Patient platforms are companies building foundational technology infrastructure that will power innovation for decades. Unlike single-purpose products, these platforms create entire ecosystems where countless other innovations can flourish, similar to how Microsoft's Windows became the foundation for thousands of software applications.

Question 2

What is platform technology?

Accepted Answer

Platform technology creates comprehensive ecosystems rather than just individual products. For example, Intuitive Surgical's da Vinci system isn't just a surgical tool—it's a complete platform including robotic hardware, specialized instruments, training programs, and ongoing support services that creates high switching costs for users.

Question 3

What is the patience premium in investing?

Accepted Answer

The patience premium refers to potential rewards for investors willing to hold platform technology positions for years rather than quarters. These companies often require extended timelines for regulatory approvals, market adoption, and ecosystem development, but may generate substantial returns as their platforms mature.

Question 4

How to invest in patient platforms stocks?

Accepted Answer

You can invest in patient platforms through Nemo's ADGM-regulated platform, which offers commission-free investing and fractional shares starting from just $1. This makes long-term infrastructure investing accessible even with small amounts, allowing you to build positions in foundational technology companies over time.

Question 5

Patient platforms investment risks?

Accepted Answer

Key risks include technology shifts that can render platforms obsolete, regulatory changes that delay development timelines, and competition from well-funded startups or tech giants. Extended investment horizons also mean capital remains tied up for years, potentially missing other opportunities during market volatility.

Question 6

Best patient platforms companies to buy?

Accepted Answer

The collection features companies like Intuitive Surgical (robotic surgery platforms), Illumina (DNA sequencing infrastructure), and ASML (semiconductor manufacturing equipment). These companies have established dominant positions in their respective fields with high switching costs and strong competitive moats.

Question 7

Why invest in patient platforms long-term?

Accepted Answer

Platform companies building essential infrastructure may generate substantial returns as their technologies achieve widespread adoption. The convergence of AI, genomics, robotics, and advanced computing creates unprecedented opportunities for companies that successfully establish dominant positions in emerging ecosystems.

Question 8

How does AI affect patient platforms investing?

Accepted Answer

AI is dramatically accelerating development timelines for platform technologies, compressing what might have taken a decade into just years. This creates a virtuous cycle where platforms generate data that trains AI systems, which then improve the platforms themselves, potentially bringing forward the timeline for investment returns.

Question 9

Patient platforms vs regular tech stocks?

Accepted Answer

Patient platforms focus on building foundational infrastructure rather than consumer-facing products. They require longer development timelines but can create virtually unassailable competitive positions with recurring revenue models, unlike regular tech stocks that may face more immediate competitive pressures.

Question 10

When will patient platforms stocks pay off?

Accepted Answer

Platform technologies often require years or decades to fully mature and realize their potential. The timeline depends on factors like regulatory approvals, market adoption, and ecosystem development. Companies with strong competitive advantages and adequate financial resources are better positioned for long-term success.

Question 11

Fractional shares patient platforms companies?

Accepted Answer

Yes, Nemo offers fractional shares for patient platforms companies starting from just $1. This allows investors to build diversified positions in expensive infrastructure stocks like ASML (which trades at premium prices) without needing large amounts of capital upfront.

Patient Platforms: The Infrastructure Builders Shaping Tomorrow's Tech

Patient Platforms: The Infrastructure Builders Shaping Tomorrow's Tech

Lula's Win Rattles Wall Street's Brazil Trio

DoorDash's $17bn Instacart Gambit Signals Delivery Wars Endgame

TikTok's Compute Hunger Could Redraw the Cloud Map

Bloom's Beat-and-Raise Hits a Cash Wall

Boeing's Biggest Headache Just Disappeared

The Unseen Architects: Why Investing in Tech's Plumbers Could Be an Idea

Forget the Penthouse, Consider the Plumbing

The Monopolists Hiding in Plain Sight

The Agonising Virtue of Patience

Deep Dive

Market & Opportunity

Key Companies

Primary Risk Factors

Growth Catalysts

How to invest in this opportunity

Frequently Asked Questions

Recent insights

Lula's Win Rattles Wall Street's Brazil Trio

DoorDash's $17bn Instacart Gambit Signals Delivery Wars Endgame

TikTok's Compute Hunger Could Redraw the Cloud Map

Bloom's Beat-and-Raise Hits a Cash Wall

Boeing's Biggest Headache Just Disappeared

Lula's Win Rattles Wall Street's Brazil Trio

DoorDash's $17bn Instacart Gambit Signals Delivery Wars Endgame

TikTok's Compute Hunger Could Redraw the Cloud Map

Bloom's Beat-and-Raise Hits a Cash Wall

Boeing's Biggest Headache Just Disappeared